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Medical Therapy for Inappropriate
Sexual Behaviors in a Teen With
Autism Spectrum Disorder
Loyal Coshway, MD,a Julia Broussard, MD,b Kruti Acharya, MD,c Karen Fried, PsyD,d
Michael E Msall, MD,e John D. Lantos, MD,b Leena Nahata, MDa

Teens with autism spectrum disorder often exhibit sexual behaviors in
public that are disturbing to parents, teachers, and peers. Some have
proposed that such behaviors can be curtailed with hormonal suppression.
There is information on the Internet suggesting that such medications work,
and some reports in the peer-reviewed medical literature support these
claims. Such medications can have serious side effects. In this paper, we
present a case in which parents requested such treatment of their teenage
son with autism spectrum disorder.

Teens with autism spectrum disorder
(ASD) often exhibit sexual behaviors
in public that are disturbing to
parents, teachers, and peers. Some
have proposed that such behaviors
can be curtailed with hormonal
suppression. In this month’s Ethics
Rounds, we present a case in which
parents request such treatment
from a pediatric endocrinologist.
We then asked experts in pediatric
endocrinology and developmental
pediatrics to comment on the
appropriate response to such a
request.

THE CASE
The mother of a 12-year-old male,
Brad, makes an appointment in the
pediatric endocrinology department
because her son has been exhibiting
inappropriate sexual behaviors
(public exposure, masturbation,
and inappropriate touching of his
younger siblings). Brad has been
diagnosed with ASD. He has cognitive
impairment and is currently in
school at the kindergarten grade
level. He cannot read. He is able to
communicate and follow simple

directions. His parents are now
afraid to leave him unattended with
younger children because of his sexual
behaviors.
Brad sees a psychiatrist who has
tried behavioral therapy as well
as medication (olanzapine and
fluoxetine). These have been
ineffective in reducing Brad’s sexual
behaviors. His parents have done
research on the Internet and found
reports that hormonal therapy to
suppress luteinizing hormone (LH)
and testosterone levels can decrease
inappropriate sexual behaviors in
cognitively impaired teens.
On examination, he is in mid-puberty.
Gonadotropins and testosterone
level show evidence of central
puberty and are consistent with this
exam. Bone age is 1 year greater
than chronological age but within
normal limits. Therefore, although
his pubertal onset was earlier than
average, there is no evidence of
endocrine pathology.
The parents are concerned that, unless
effective treatment can be found, Brad
may cause harm to the other children
in the house or at school. Brad himself
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is unable to consent due to cognitive
limitations. Would it be appropriate
to try hormonal therapy as a means
to reduce or eliminate Brad’s
inappropriate sexual behavior?

Loyal Coshway, MD, and
Leena Nahata, MD, Pediatric
Endocrinologists, Comment
In this case, a question has been
raised about using luteinizing
hormone releasing hormone (LHRH)
agonists to reduce sexual behavior.
LHRH agonists are typically used
for the suppression of centrally
mediated precocious puberty,
defined as puberty occurring before
9 years of age in a male. They are
administered via monthly or 3
monthly injections and are also
available as a 1 year depot implant.
LHRH agonists, such as leuprolide
and triptorelin injections, have been
used for the court-ordered treatment
of adult paraphilia (off-label
indication).1,2 Use of leuprolide in an
adult autistic male living in a group
home was reportedly successful in
reducing inappropriate behaviors
and allowing him to continue to
live in the community.3 Treatment
measures, including sexual education
and the antiandrogen flutamide,
had been ineffective, resulting in
temporary police custody for public
sexual behaviors toward other
people.3 Despite these reports, it is
unclear if pubertal suppression for
inappropriate sexual behaviors in
this young autistic child is ethically
sound. There is minimal evidence
supporting the use of LHRH agonist
therapy for pediatric hypersexual
behavior. In addition, there are
possible side effects, and this patient
would be unable to consent to
therapy because of age and cognitive
limitations. Thus, the decision to
use this treatment would need to be
made carefully after ensuring that
benefits outweigh possible harm
and acknowledging that the efficacy
would be uncertain.

In terms of potential benefits, LHRH
agonists induce hypogonadism (ie,
lower testosterone levels) and may
therefore suppress hypersexual
behaviors. Treatment of hypersexual
behaviors with these agents has
mainly been reported in adults
who have committed sexual crimes,
including pedophilia, exhibitionism,
sadism, rape, and voyeurism. Based
on review of 13 studies, Briken et
al1 concluded that LHRH agonists
offer a reasonable treatment option
for adult paraphilia; however,
conclusions were weakened due to
the lack of randomized controlled
trials, differing methodology, and the
use of patient self-report as opposed
to objective measures of behavior.
The authors ultimately advised that
LHRH agonist use could be justified
if the individual poses a danger to
others, but that patients should give
informed consent because of the risk
of side effects.1
There are increased risks of
using LHRH agonists in a growing
child, as pubertal suppression
interrupts several natural processes.
Testosterone is required for pubertal
growth spurt, increase in lean muscle,
decrease in fat, and increase in bone
density. In the case of someone
with chronic mental disability, it
is unclear when such treatment
could be successfully discontinued,
and side effects of longstanding
hypogonadism include osteoporosis
and higher incidence of fracture.4
Short term side effects include
injection site pain, abscess or local
reaction, and growth suppression
from loss of testosterone-mediated
growth.5 Of note, most families
cannot afford leuprolide without
insurance approval due to the high
cost (single injections range from
$1413 to $8481 depending on the
dose and duration).
Additionally, it is important to
acknowledge the difference between
adults with sex addictions/criminal
behavior and children with autism
and hypersexual behavior. Based on

a survey of 100 parents of children
age 9 to 38 years with autism,
inappropriate sexual behaviors
were frequent; 65% touched
their private parts in public, 23%
masturbated in public, 18% touched
the opposite sex inappropriately, and
14% masturbated with an unusual
object.6 Other problem behaviors
include undressing or touching
body parts in public and sexual
fetishism.7 Increased masturbation
in autism may be a self-stimulatory
behavior and related to sensory
abnormalities.8 Such behaviors can
be challenging for parents, teachers,
and other caregivers, leading to
curtailment of routine activities.
For individuals with autism,
underlying problems are lack
of social competence and poor
communication. Because of an
inability to pick up on social cues,
moderate and severely autistic
patients may be unaware that public
exposure or masturbation is taboo.3
Koller9 writes that sexual desire is
a natural part of human behavior,
and that appropriate expression is
enabled by age and developmentally
appropriate education on pubertal
development, sexual desires,
pregnancy, and sexually transmitted
diseases. Newer literature suggests
that high-functioning autistic
individuals have fairly typical sexual
experiences as adults. However,
individuals with autism were far
less likely to receive education
about sexuality, contraception, and
sexually transmitted diseases from
their parents or teachers; instead,
higher-functioning individuals
with autism obtained information
from media such as television.8
Parents of low-functioning autistic
children often failed to teach even
basic sexual education: puberty,
reproduction, reporting sexual
victimization, and that it is wrong
to coerce sexual activity.8 Koller
outlines specific protocols for
excessive public masturbation,
including interrupting the behavior,
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reminding the person of appropriate
time and place, redirection, and
allowing masturbation in private
because it may be the only type of
sexual satisfaction available to that
person in their lifetime. Specialists
do caution that adult sexual
relationships involving a person with
autism should be viewed with great
caution because sexual relationships
require empathy, tenderness, and
care, and one must recognize that
the majority of individuals with
autism have great difficulty relating
to other people.9 Developmentally
appropriate sexual education and
behavior expectations should be
taught by parents and teachers and
reinforced by physicians.
When behavioral therapy
has not been effective alone,
pharmacotherapy in autistic
adolescents has been reported in
several case series with variable
rates of success. Two studies describe
the successful use of mirtazapine and
β-blockers to reduce inappropriate
sexual behavior and excessive
masturbation.6,7 However, in a case
series of 25 autistic males aged 15
to 21 years, medications, including
neuroleptics and selective serotonin
reuptake inhibitors (SSRIs), were
not universally effective.10 Sajith
et al11 reviewed pharmacologic
treatment of inappropriate sexual
behaviors in intellectually disabled
men and reported that testosterone
suppressing medications, including
LHRH agonists, were successful
in reducing inappropriate sexual
behaviors in adult males with
intellectual disability (ID). However,
the authors advised against use in
children <18 years old because of the
concern for side effects.
Based on review of these studies,
Brad’s family’s concerns about his
behavior are understandable, but the
risks associated with LHRH agonists
in a growing child appear to outweigh
the benefits. Though committing to
weekly therapy and waiting several
weeks to months to see potential

benefit from the SSRI may be difficult,
this seems to be the most optimal
approach for the patient.

Kruti Acharya, MD, Michael E.
Msall, MD, and Karen Fried, PsyD
(Developmental Pediatrics and Child
Psychology) Comment
The scenario presented is not
uncommon. Parents of children
with IDs often reach out to medical
providers around the onset of
puberty for guidance, education, and
support. Some parents seek care
to learn what to expect to prepare
themselves; others, as in this case,
want to know if a specific treatment
or procedure is indicated. If the
latter, parents often request a drastic
procedure like hormonal therapy
because of confusion and fear. Brad’s
parents are fearful that Brad could
harm himself or others and because
of their fear, they are considering
limiting his reproductive rights. Their
fears are not groundless; individuals
with IDs have faced criminal charges
and potential legal action for sexual
offenses.12
Nevertheless, we feel that it would
not be appropriate to try hormonal
therapy. Used in males to suppress
gonadotropins and androgens,
hormonal therapy is a form of
chemical sterilization even if used
for the sole intent of curtailing
inappropriate behavior. As such,
this decision must be viewed in the
long historical context of involuntary
sterilization of individuals with
IDs. In the early 20th century,
surgical sterilization was part of
a nationwide eugenics program
designed to prevent reproduction in
individuals with IDs. In 1927, these
eugenic practices were upheld by
the US Supreme Court decision in
Buck v. Bell.13 After World War II,
forced sterilization of individuals
with IDs gradually lost favor. Now,
many states advocate for selfdetermination and have statutes
regulating sterilization, banning the
procedure altogether or requiring

additional legal protections. The
United Nations Convention of
the Human Rights of People with
Disabilities recognizes fertility as an
inherent human right.14
Brad is a preadolescent with ASD
and cognitive impairment. He clearly
lacks capacity to consent to medical
treatment. It is not only critical to
understand what Brad’s limitations
are in communication and learning,
but also what his functioning is with
respect to self-care, communication,
social interaction with siblings
and peers, and participation in
educational, family, and community
activities. Individuals with ID/
ASD have a range of strengths and
limitations in communication and
adaptive skills. Understanding if
Brad can do basic toileting, dressing,
bathing, and grooming allows us to
understand what Brad’s touching or
masturbation might mean to him. We
should know if he has exhibited other
challenging behaviors.
The central question in his
management should focus on
what Brad can do safely without
supervision. This will turn on
his ability to understand and
communicate. Because of his
impaired cognition and potential
social impairment related to his
ASD diagnosis, Brad likely does not
possess the insight that his behavior
is socially unacceptable. But could
he come to understand this? Because
people with ID are often viewed as
asexual, they often do not receive
robust education about sexual health3
and, therefore, have limited sexual
knowledge. Galea et al15 reported
that 96 Australian adults with ID had
low knowledge scores about puberty,
menstruation, menopause, sexuality,
safe sex practices, sexual transmitted
infections, and contraception. Yet
many people with ID have happy
and rewarding sexual experiences.
Chamberlain et al16 found that one
half of the sample of 11- to 23-yearold women with mild ID, 32% of
women with moderate ID, and 9%
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of women with severe ID attending
a multiservice clinic in the United
States and living in the community
had engaged in consensual
intercourse. Brad’s actions may
represent normal sexual urges being
acted on in inappropriate settings.

people with ID, plain language but
accurate terms should be used to
describe body parts. Matching the
person’s language with accurate
terms, visual material, and models
may be very helpful, particularly for
individuals with limited verbal skills.

Before hormonal therapy is
considered, Brad should receive
intensive behavior analysis
treatment.17 Behavioral therapy
is a broad term that, generally
speaking, recognizes that human
behavior is the product of external
environmental feedback and
that behavior can be altered by
manipulating the environmental
cues and input. Provided by trained
behavioral professionals rather than
psychiatrists, applied behavioral
analysis therapy is a specific type of
behavioral therapy that can be very
successful for individuals with ASD
to reduce or control problematic
behavior.18

His parents may argue that hormonal
therapy could benefit Brad because
it will reduce the likelihood that
he will face legal or criminal action
because of his behavior. Because
other treatments are available,
the risk to Brad’s fertility and of
unknown long-term side effects
outweighs the short-term benefit
that Brad may experience. Moreover,
hormonal therapy will reduce normal
sexual feelings, which arguably could
negatively impact Brad’s quality of
life.

In addition, before hormonal therapy
is considered, Brad should receive
developmentally appropriate sexual
health education that includes
discussion of the basic facts of life,
reproduction, sexual intercourse,
human growth and development,
human reproduction and anatomy,
and self-pleasuring/masturbation.19
Individuals with ID, regardless of
cognitive level, can be taught what
is or is not appropriate and healthy
sexual behavior. They can generally
be taught how to engage in sexual
behavior within socially appropriate
limits.There are evidence-based
educational resources about puberty
and healthy sexuality for individuals
with ID, including children. Centers
for independent living can provide
resources and allies for providing
education and peer mentoring
around relationships, intimacy,
sexuality, sexual expression, and
parenting. Curricula need to be
explicit and should be adapted to
the individual’s level of cognition.
When discussing sexual issues and
developing education programs for

Providers should educate parents
about the potential risks of the
requested treatment and offer
alternate choices (ie, developmentally
appropriate sex education and
intensive applied behavioral analysis
therapy). Sexuality is closely related
to a person’s self-concept and selfesteem. The issue of sexuality as
a human right for all individuals,
including persons with ID, should be
normalized, not ignored or avoided.20

Julia Broussard, Pediatric
Endocrinologist, Comment
Brad is a 12-year-old male with
ASD and cognitive impairment who
has been exhibiting inappropriate
sexual behaviors. Behavioral therapy
and pharmacological therapy with
olanzapine and fluoxetine have been
ineffective in reducing Brad’s sexual
behaviors. On physical exam, he is in
mid-puberty and gonadotropins and
testosterone levels are consistent
with exam and show central puberty,
normal for his age. Bone age is within
normal limits for his chronological
age. He can communicate and follow
simple directions but is unable to
consent due to cognitive limitations.
Because of Brad’s inappropriate
sexual behaviors, his parents are

afraid to leave him unattended
with younger children. They are
concerned that, unless effective
treatment can be found, Brad may
cause harm to other children in
the house or at school. Parents did
research on the Internet and found
reports that hormonal therapy
can decrease inappropriate sexual
behaviors in cognitively impaired
teens.
There are a number of values and
principles in conflict. We cannot
apply the principle of respect for
autonomy because Brad’s cognitive
impairment limits his ability to act
autonomously. Instead, we look
to the principle of beneficence. In
this case, though, it is difficult to
determine what is best for Brad.
His parents think that medication
to suppress his sexual desires and
behavior would be best. But they may
be thinking more about the harms
that might occur to other children.
In this case, both Brad and the
children he inappropriately touches
are vulnerable entities. Brad’s sexual
behavior in public is against society’s
norms. His parents are rightfully
concerned about Brad’s and the other
children’s safety.
Would hormonal medication help?
Geier and colleagues21 have reported
a “Lupron protocol” for people with
autism. Hormonal therapy for this
purpose was mainly described in late
adolescents and adults, where the
side effects of such therapy are less
worrisome than they are for younger
teens.3 There are no evidencebased studies in the literature to
support the use of hormonal therapy
in teenagers with autism for the
purpose of reducing aggressiveness
and inappropriate sexual behaviors.
Multiple pediatric endocrinologists
dismissed this kind of treatment in
a consensus statement on the use
of gonadotropin-releasing hormone
analogs in children.22 Lupron
treatment in adolescents with autism
is not approved by the US Food and
Drug Administration for the above
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mentioned purpose. It poses
significant risks such as: decreased
linear growth velocity with
subsequent short stature and
transitory decreased bone mineral
density during gonadotropinreleasing hormone analogs
treatment. Also, it is not a longterm treatment option, and it will
not lead to a longstanding
improvement in the patient’s
inappropriate sexual behaviors.
Thus, it seems that hormonal
therapy for Brad is more likely to
cause harm than benefit.
What, then, can be done? In Brad’s
case, behavioral intervention and
psychotropic medications did
not have a positive impact on his
inappropriate sexual behaviors. But
they may not have been the right
medications or therapies. Griffiths et
al,23 Schopler et al,24 and Ward et al,25
suggest that treatment approaches
for a case like Brad’s include
inappropriate behavior suppression
using structured teaching
approaches, reinforcing alternative
behaviors, development of social
skills, and coping strategies. Children
with autism may benefit from early
education on social skills and sexual
behavior; this can be accomplished
by a concerted effort involving family,
teachers, peers, and other community
members. In addition, alternative
medications from the same class that
includes fluoxetine (an SSRI) may
be trialed for an adequate period of
time. The doctor in this case needs to
explain to the parents the inaccuracy
of the data on the Internet and the
lack of evidence that would make
hormonal treatment indicated for
this purpose. They need to help the
parents find appropriate resources to
institute an individualized behavior
management plan.

John D. Lantos, MD, Pediatrician and
Bioethicist, Comment
This case highlights 3 important
points. First, parents today get a lot
of information, and misinformation,

on the Internet. Physicians need to
be prepared to answer questions that
arise from Internet searches and to
do so with both respect and humility.
Sometimes the information will be
wrong. But sometimes parents can
gain important insights that improve
patient care. Second, there are many
myths surrounding autism and
cognitive delay that might interfere
with good patient care. As in other
areas, pediatricians should consult
with experts who can help separate
myth from fact. One problem that may
arise for many providers is in finding
experts. Pediatricians outside of major
cities or without access to major
academic centers may have trouble
finding consultants. Parents may have
to travel hours to see a knowledgeable
specialist. This is an area in which
telemedicine could be beneficial.
Finally, the respondents in this case all
endorse a process of shared decision
making and staged interventions.
It is usually best to try less invasive
treatments before more invasive
ones. Most parents will understand
and support this if we take the time
to explain our reasoning. In the care
of children with complex chronic
conditions, parents and pediatricians
need to work together.
The following Web sites can serve
as resources for sexual health
education:
www.shfpa.org.au/
www.agac.org.au/links/
www.cddh.monash.org/assets/
supporting-women-gp.pdf
www.sexualhealth.com
www.kc.vanderbilt.edu/
healthybodies/ (includes a free
online packet entitled “Healthy
Bodies for Boys: A parent’s guide
for Boys with disabilities.”)
www.stwwgepublications.com/
pages/publications.html (includes
a brochure entitled “Sex Education
for Parents of Children with Autism
Spectrum Disorders”)
www.lookingglass.org

ABBREVIATIONS
ASD: Autism spectrum disorder
ID: intellectual disability
LH: luteinizing hormone
LHRH: luteinizing hormone
releasing hormone
SSRI: selective serotonin
reuptake inhibitor
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